Scarica l'app Stockscreener
22.10
2.99%
-0.68
Dopo l'orario di chiusura:
22.36
0.26
+1.18%
Biodesix Inc Borsa (BDSX) Ultime notizie
Biodesix Inc (BDSX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biodesix Inc (BDSX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BDSX|Biodesix Inc|Price:21.900|Chg%:-0.100 - TradingKey
Biodesix Inc (BDSX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Biodesix Inc (BDSX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
Biodesix Inc (BDSX) Income Statement - TradingKey
Biodesix Inc (BDSX) Balance Sheet - TradingKey
Biodesix Inc (BDSX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biodesix Inc (BDSX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BIAF vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now? - Yahoo Finance
Biodesix Inc (BDSX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BDSX|Biodesix Inc|Price:22.000|Chg%:-0.320 - TradingKey
Biodesix to report Q2FY26 results on August 5, 2026 - scanx.trade
Biodesix to Report Second Quarter 2026 Financial Results on August 5 - Quiver Quantitative
Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026 - Caledonian Record
Biodesix management will give a business update on Aug. 5 - Stock Titan
Biodesix Inc. (BDSX) Holds Steady Near Resistance as Support Levels Remain KeyFactor Momentum - dars.gov.et
Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Biodesix Inc. (BDSX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade - MSN
AIGH Capital Management LLC Buys Shares of 758,328 Biodesix, Inc. $BDSX - MarketBeat
Biodesix Inc. (BDSX) Edges Lower Amid Consolidation Near ResistanceMFI Overbought - dars.gov.et
Biodesix (BDSX) chair converts 1,361 RSUs and updates holdings - Stock Titan
Biodesix Inc. (BDSX) Gains Momentum: Key Levels to Watch After 3% RallyPre-Earnings Momentum - dars.gov.et
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell Microcap Value Benchmark Index - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell 3000E Growth Benchmark - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell Microcap Index - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell 3000E Value Benchmark - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell 3000E Index - marketscreener.com
Enterprise value to revenue forward of Biodesix, Inc. – NASDAQ:BDSX - TradingView
Price to earnings forward of Biodesix, Inc. – NASDAQ:BDSX - TradingView
Price to book forward of Biodesix, Inc. – NASDAQ:BDSX - TradingView
Biodesix, Inc. Actuals & Estimates (NASDAQ:BDSX) - TradingView
Biodesix (BDSX) Stock Gets Fair Value Bump As Analysts Back Growth Path - Yahoo Finance
Biodesix, Inc. Actuals & Estimates (BOATS:BDSX) - TradingView
BDSX Forecast — Price Target — Prediction for 2027 - TradingView
Biodesix Company Profile & Introduction - Moomoo
BDSX Initiated Coverage by Roth Capital -- Price Target Set at $32 - GuruFocus
Roth Capital Initiates Biodesix at Buy With $32 Price Target - marketscreener.com
Biodesix (BDSX) Coverage Initiated with Positive Outlook - GuruFocus
Biodesix | SCHEDULE 13G/A: Others - Moomoo
Biodesix (BDSX) Surges 10.43%: Key Levels and What Lies AheadLow Volume Node - dars.gov.et
Biodesix (BDSX) surges 10.5%: Is this an indication of further gains? - MSN
Biodesix Inc. (BDSX) Surges Over 10% – Key Levels to WatchBuffered ETF - dars.gov.et
Are medical stocks lagging Biodesix (BDSX) this year? - MSN
Biodesix (BDSX) Surges 10.5%: Is This an Indication of Further Gains? - Yahoo Finance
BDSX News | BIODESIX INC (NASDAQ:BDSX) - ChartMill
Soleus discloses 525,241-share (5.1%) stake in Biodesix (BDSX) - Stock Titan
Canaccord raises Biodesix stock price target to $27 on growth outlook By Investing.com - Investing.com Australia
Canaccord raises Biodesix stock price target to $27 on growth outlook - Investing.com UK
Biodesix Inc. (BDSX) Surges More Than 10% as Diagnostic Speculation Heats UpIPO Entry Watch - dars.gov.et
1.13%
0.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):